Anthropic priced 980 million shares at $83 each on Nov. 18, including shares sold by existing investors. The company sold about 956.4 million shares, worth roughly $79.38 billion before underwriting costs; Nasdaq trading under the ticker ANT was scheduled for Nov. 19.
Bitquery counted about $2 billion in trading across three Hyperliquid markets from their launch in August through its Nov. 18 analysis. About $1.42 billion came in the preceding 30 days, when roughly 19,000 accounts traded the contracts. These were perpetual futures, which let traders bet on the stock’s price without receiving shares or an IPO allocation. Activity on the two largest markets reached 8.5 times a typical day’s volume after Anthropic disclosed its proposed price range on Nov. 10.
Bachelier said on-chain derivatives and oracles gave traders access to price exposure that was otherwise difficult to obtain, while access to the actual IPO depended on an allocation. Kraken offered eligible customers a separate way to request share-backed ANTx tokens at the IPO price, with underwriters deciding how many shares, if any, applicants received. Kraken says each token is backed by an Anthropic share held in custody and carries no shareholder voting rights.
Bachelier said repo trading and funding, rather than IPOs or weekend trading, would be of greater interest to the market. In a repo, a party sells securities for cash and agrees to buy them back later at a set price. The New York Fed describes the arrangement as similar to a short-term, securities-backed loan.
The Depository Trust Company launched a tokenization service in October, with 20 participants signed up for access. Eligible firms can convert certain securities held at DTC into tokenized entitlements and transfer them to digital wallets while retaining the underlying rights. A DTC production event in July included a U.S. Treasury repo transaction, as well as equity token transfers and settlement. Its program covers selected Russell 1000 stocks, major-index ETFs and U.S. Treasuries.

Comments (0)
No comments yet. Be the first!